Because traditional methods of chemical discovery and selection relied on "natural" pathways (those formed by sources found in the wild and brought into the library), creation of the requisite number of peptides for new drug discovery was impractical.
Food and Drug Administration | Drug Enforcement Administration | United Nations Industrial Development Organization | International Development Association | United Nations Conference on Trade and Development | International Bank for Reconstruction and Development | drug | International Fund for Agricultural Development | African Development Bank | USL Premier Development League | United States Agency for International Development | Integrated development environment | Food and Drug Administration (United States) | Asian Development Bank | United States Department of Housing and Urban Development | Inter-American Development Bank | Millennium Development Goals | Organisation for Economic Co-operation and Development | Illegal drug trade | European Bank for Reconstruction and Development | cannabis (drug) | Steinhardt School of Culture, Education, and Human Development | West African Development Bank | development | NBA Development League | International Institute for Management Development | Software development kit | General Educational Development | software development | research and development |
Critical Path Institute, organization for improvement of the drug development process
Zarling was a S. L. Brown Scholar and holds a BA with Honors in Biology, a MA in Molecular Biology/ Biological Sciences from Dartmouth College, a Ph.D. in Virology/Oncology, with emphasis on pharmaceutical drug development, from Baylor College of Medicine and an Executive MBA in Marketing/Finance from Pepperdine University.
Systematic Evolution of Ligands by Exponential Enrichment, a molecular biology technique used in drug development
He is also the co-founder of three pharmaceutical companies; CDD (Co-ordinated Drug Development) (since acquired by Vectura Group); Danbiosyst (UK) Ltd (sold to West Pharmaceutical Services and then to Archimedes) and Pharmaceutical Profiles Ltd.